Silybin b and cianidanol inhibit Mpro and spike protein of SARS-CoV-2: Evidence from in silico molecular docking studies

  1. Srivastava, R.
  2. Tripathi, S.
  3. Unni, S.
  4. Hussain, A.
  5. Haque, S.
  6. Dasgupta, N.
  7. Singh, V.
  8. Mishra, B.N.
Revue:
Current Pharmaceutical Design

ISSN: 1873-4286,  1381-6128

Année de publication: 2021

Volumen: 27

Número: 32

Pages: 3476-3489

Type: Article

DOI: 10.2174/1381612826666201210122726 GOOGLE SCHOLAR
La source de données: Scopus